Literature DB >> 29965804

Risk of Venous Thromboembolic Events in Patients With Cancer Treated With Aflibercept: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Raju Kanukula1, Shruthi Ganta2, Yashaswee Sirumalla3, Abdul Salam4, Ravali Baddam5, Bhuvana C Pasupuleti5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 29965804     DOI： 10.1097/MJT.0000000000000805

Source DB:  PubMed          Journal:  Am J Ther        ISSN： 1075-2765            Impact factor:   2.688


× No keyword cloud information.
  2 in total

1.  Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment.

Authors:  Pu Ge; Ning Wan; Xiao Han; Xinpei Wang; Jinzi Zhang; Xiaoyi Long; Xiaonan Wang; Ying Bian
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

Review 2.  Cancer Therapy-Associated Thrombosis.

Authors:  Steven P Grover; Yohei M Hisada; Raj S Kasthuri; Brandi N Reeves; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-11       Impact factor: 8.311
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.